Related Experiment Videos
Gastric cancer presenting with obstructive jaundice.
Norio Shiraishi1, Kazuhiro Yasuda, Kenji Kakisako
1First Department of Surgery, Oita Medical University, 1-1 Idaigaoka, Hasama-machi, Oita 879-5593, Japan.
Summary
Gastric cancer rarely causes obstructive jaundice, a condition linked to poor outcomes. Treatments like chemotherapy and percutaneous transhepatic biliary drainage (PTBD) may not extend life but can significantly improve quality of life for these patients.
Area of Science:
- Gastroenterology
- Oncology
- Hepatology
Background:
- Obstructive jaundice is an uncommon presentation of gastric cancer.
- Gastric cancer with obstructive jaundice is associated with a poor prognosis.
Purpose of the Study:
- To describe the clinical presentation, treatment, and outcomes of gastric cancer patients with obstructive jaundice.
- To evaluate the role of chemotherapy and PTBD in managing these patients.
Main Methods:
- Case series of five patients with gastric cancer presenting with jaundice.
- Treatment modalities included surgery, chemotherapy, and percutaneous transhepatic biliary drainage (PTBD).
- Treatment decisions were based on cancer staging.
Main Results:
- Two patients had primary gastric cancer; three had recurrent disease.
- Treatments were individualized based on cancer stage.
- While survival prolongation was limited, chemotherapy and PTBD offered palliative benefits.
Conclusions:
- Gastric cancer presenting with obstructive jaundice is rare and carries a poor prognosis.
- Chemotherapy and PTBD can be valuable in improving the quality of life for patients with gastric cancer and obstructive jaundice, even if survival is not significantly extended.